Credential Securities’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$662K Sell
7,141
-494
-6% -$48.2K 0.15% 97
2018
Q1
$722K Sell
7,635
-101
-1% -$11.1K 0.17% 92
2017
Q4
$749K Sell
7,736
-144
-2% -$13.6K 0.18% 97
2017
Q3
$700K Buy
7,880
+100
+1% +$7.61K 0.19% 100
2017
Q2
$564K Sell
7,780
-97
-1% -$6.52K 0.17% 111
2017
Q1
$513K Sell
7,877
-109
-1% -$6.85K 0.18% 113
2016
Q4
$500K Sell
7,986
-312
-4% -$19K 0.2% 116
2016
Q3
$523K Sell
8,298
-22
-0.3% -$1.42K 0.24% 109
2016
Q2
$515K Sell
8,320
-88
-1% -$5.36K 0.27% 109
2016
Q1
$480K Buy
8,408
+28
+0.3% +$1.56K 0.28% 110
2015
Q4
$496K Buy
8,380
+114
+1% +$6.57K 0.33% 99
2015
Q3
$450K Buy
8,266
+124
+2% +$8.07K 0.31% 97
2015
Q2
$547K Buy
8,142
+117
+1% +$7.64K 0.35% 91
2015
Q1
$470K Buy
8,025
+561
+8% +$33.9K 0.3% 97
2014
Q4
$488K Buy
7,464
+22
+0.3% +$1.39K 0.32% 91
2014
Q3
$436K Buy
7,442
+454
+6% +$25.2K 0.29% 94
2014
Q2
$394K Buy
6,988
+561
+9% +$29.4K 0.26% 103
2014
Q1
$330K Buy
+6,427
New +$325K 0.25% 105

Other funds holding ABBV

Credential Securities's ABBV Position: Q2 2018 in Review

Credential Securities reduced its AbbVie (ABBV) stake by 6.5% in Q2 2018, selling an estimated $48.2K and leaving 7,141 shares worth $662K. The position accounts for 0.15% of the portfolio, ranked #97.

Credential Securities first reported a position in ABBV in Q1 2014 and has held it in 18 quarters since. The position peaked at $749K in Q4 2017. 1,997 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

  • Credential Securities held 7,141 shares of AbbVie worth $662K as of Q2 2018.
  • Credential Securities sold 494 AbbVie shares in Q2 2018, an estimated $48.2K.
  • AbbVie made up 0.15% of Credential Securities's portfolio in Q2 2018, its #97 holding.
  • Credential Securities first reported a position in AbbVie in Q1 2014 and has held it in 18 quarters since.
  • Credential Securities's AbbVie position peaked at $749K in Q4 2017.
  • 1,997 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Credential Securities's 13F filing for Q2 2018, filed 21 Jul 2025.